Por qu茅 los CDC recomiendan el nuevo refuerzo contra covid para todos
El Comit茅 Asesor sobre Pr谩cticas de Inmunizaci贸n de los CDC vot贸 13-1 a favor de la moci贸n despu茅s de meses de debate sobre si limitar los refuerzos a grupos de alto riesgo.
Why the CDC Has Recommended New Covid Boosters for All
As covid-19 hospitalizations tick upward with fall approaching, the CDC says it鈥檚 time for new boosters 鈥 and not only for those at highest risk of serious disease. Here are seven things you need to know.
A pesar de las amplias recomendaciones para el refuerzo anticovid actualizado publicadas el oto帽o pasado, s贸lo el 17% de la poblaci贸n la recibi贸, y alrededor del 43% de las personas de 65 a帽os o m谩s.
Pfizer and Moderna Are Pushing the New Covid Booster. Should You Get It? The CDC Is About to Decide.
Chances are, if you aren鈥檛 older, chronically ill, or obese, you don鈥檛 need a forthcoming covid vaccine to stay out of the hospital. But it probably wouldn鈥檛 hurt.
5 Things to Know About the New Drug Pricing Negotiations
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
The Real Costs of the New Alzheimer鈥檚 Drug, Most of Which Will Fall to Taxpayers
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer鈥檚, experts say.
What You Need to Know About the Drug Price Fight in Those TV Ads
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients.
Why the Next Big Hope for Alzheimer鈥檚 Might Not Help Most Black Patients
Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.
El cisplatino y el carboplatino son algunos de los medicamentos que escasean, as铆 como otros 12 contra el c谩ncer, pastillas para el trastorno por d茅ficit de atenci贸n con hiperactividad, anticoagulantes y antibi贸ticos.
Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can鈥檛 Get Meds
A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.
La Comisi贸n Federal de Comercio est谩 actuando contra las empresas farmac茅uticas y los intermediarios del sector, como parte de la campa帽a de la administraci贸n Biden para reducir los precios de los medicamentos en las farmacias.
A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
PBMs, the Brokers Who Control Drug Prices, Finally Get Washington鈥檚 Attention
Drugmakers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Congress is finally on board, too, but will it matter?
La empresa farmac茅utica que prosper贸 sin crear ni un solo medicamento
Aunque Horizon afirma que ahora tiene 20 f谩rmacos en desarrollo, en sus 15 a帽os de existencia a煤n no ha obtenido la licencia de un producto de su creaci贸n.
The Drug Company That Prospered Without Creating Any Drugs
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Sen. Sanders Shows Fire, but Seeks Modest Goals, in His Debut Drug Hearing as Health Chair
The Vermont independent and former presidential candidate was all fire and brimstone at his first hearing on drug prices as head of the Senate HELP Committee. He also pursued a more modest goal of covid vaccine price reductions. It isn鈥檛 clear whether Sanders will succeed in even that, but he has put affordability front and center.
La insulina representa lo perverso del sistema sanitario estadounidense, ya que los precios de venta de este medicamento centenario, del que dependen 8,4 millones de estadounidenses para sobrevivir, se quintuplicaron en dos d茅cadas.
Why Does Insulin Cost So Much? Big Pharma Isn鈥檛 the Only Player Driving Prices
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but it鈥檚 the arbitrators that jack up prices for those who can least afford them.
鈥榃e Ain鈥檛 Gonna Get It鈥: Why Bernie Sanders Says His ‘Medicare for All’ Dream Must Wait
As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of 鈥淢edicare for All鈥 maps out his strategy for negotiating with Republicans 鈥 and Big Pharma.
Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients
Pharmacy closures by two of the biggest home infusion companies point to grave shortages and dangers for patients who require IV nutrition to survive.